Literature DB >> 17072949

p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids).

Basak Doganavsargil1, Banu Sarsik, Fatma Secil Kirdok, Ahmet Musoglu, Muge Tuncyurek.   

Abstract

AIM: To investigate the expression of cyclin-dependent kinase inhibitors p21 and p27 in gastric well differentiated endocrine tumors (GWDET) (ECL-cell carcinoids).
METHODS: The expressions of p21 and p27 were examined immunhistochemically in endoscopic biopsy specimens from 16 patients matching the diagnostic criteria of GWDET. Percentage of positive nuclear staining either weak or strong was noted. The association of immunoexpressions with age, gender, tumor localization, multifocality and accompanying chronic atrophic gastritis, neuroendocrine cell hyperplasia (NEH), neuroendocrine dysplasia (NED), intestinal metaplasia (IM), Ki-67 proliferation index and clinical outcome were also evaluated.
RESULTS: All cases expressed p27 with a mean expression score of 43.6%, while 31.3% of the cases showed any p21 expression. p21 and p27 immunoexpressions were significantly correlated with each other (P < 0.01), and the p21-expressing group had higher p27 expression scores (68% vs 22%). p21 and p27 expressions were lower in women, in non-atrophic mucosa and cases whose tumors were located somewhere other than fundus without submucosal extension. On contrary, p21 and p27 expressions were higher in males and the patients with submucosal extension and atrophic gastritis. Cases presenting lower p27 scores had solitary tumors showing neither NEH-NED nor IM. Despite, cases with lower p21 expression presented multifocal tumors accompanied by NEH-NED. However, no correlation of p21 and p27 expressions was found with age and Ki-67 expression.
CONCLUSION: p27 is widely expressed in GWDETs, while p21 expression is sparse and observed in two thirds of the cases. Loss of p21 and p27 expressions may be correlated with different carcinoid tumor subtypes; however, more studies are needed to assess the role of these prospective markers in gastrointestinal endocrine tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072949      PMCID: PMC4088134          DOI: 10.3748/wjg.v12.i39.6280

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Aberrant p27kip1 expression in endocrine and other tumors.

Authors:  R V Lloyd; L Jin; X Qian; E Kulig
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 2.  p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.

Authors:  R V Lloyd; L A Erickson; L Jin; E Kulig; X Qian; J C Cheville; B W Scheithauer
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

3.  Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significance.

Authors:  H Matsushima; T Sasaki; T Goto; Y Hosaka; Y Homma; T Kitamura; K Kawabe; A Sakamoto; T Murakami; R Machinami
Journal:  Hum Pathol       Date:  1998-08       Impact factor: 3.466

4.  Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

Authors:  K Polyak; M H Lee; H Erdjument-Bromage; A Koff; J M Roberts; P Tempst; J Massagué
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

5.  Clinical management of gastric carcinoid tumors.

Authors:  H Ahlman; L Kölby; L Lundell; L Olbe; B Wängberg; G Granérus; L Grimelius; O Nilsson
Journal:  Digestion       Date:  1994       Impact factor: 3.216

6.  Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature.

Authors:  Shu-Duo Xie; Lin-Bo Wang; Xiang-Yang Song; Tao Pan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

7.  Apoptosis and expression of bcl-2 protein are inverse factors influencing tumour cell turnover in primary carcinoid tumours of the lung.

Authors:  T K Zirbes; J Lorenzen; S E Baldus; S P Moenig; U Wolters; A Ottlik; J Thiele; A H Hölscher; H P Dienes
Journal:  Histopathology       Date:  1998-08       Impact factor: 5.087

Review 8.  Biology and management of gastric carcinoid tumours: a review.

Authors:  Irvin M Modlin; Mark Kidd; Kevin D Lye
Journal:  Eur J Surg       Date:  2002

9.  Gastric carcinoids--a changing trend.

Authors:  Vinayak Hegde; K M Mohandas; Mukta Ramadwar; Parul Shukla; Shaesta Mehta
Journal:  Indian J Gastroenterol       Date:  2003 Nov-Dec

10.  Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.

Authors:  Jeannette Philipp-Staheli; Kyung-Hoon Kim; Denny Liggitt; Kay E Gurley; Gary Longton; Christopher J Kemp
Journal:  Oncogene       Date:  2004-01-29       Impact factor: 9.867

View more
  3 in total

1.  Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.

Authors:  Sinju Sundaresan; Anthony J Kang; Michael M Hayes; Eun-Young K Choi; Juanita L Merchant
Journal:  Gut       Date:  2016-02-09       Impact factor: 23.059

2.  Histopathological classification and follow-up analysis of chronic atrophic gastritis.

Authors:  Yang-Kun Wang; Lan Shen; Tian Yun; Bin-Feng Yang; Chao-Ya Zhu; Su-Nan Wang
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

3.  Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma.

Authors:  K Holmes; B Egan; N Swan; C O'Morain
Journal:  Curr Genomics       Date:  2007-09       Impact factor: 2.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.